Decellularised Dermis Allograft for the Treatment of Chronic Venous Leg Ulceration

Stopped DMC noted that the primary end point of healed index ulcer at 12 weeks was reached only in 11.5%, whereas a higher figure of 42.5% had been used for the original power calculation, suggesting the trial is significantly underpowered.

Conditions

• Venous Ulcer
• Allograft

Interventions

• OTHER: dCELL® Human Dermis (decellularised dermal skin allograft - DCD)
• OTHER: Compression bandaging therapy

Sponsor

Imperial College London

Collaborators

• [object Object]
• [object Object]
• [object Object]
• [object Object]
• [object Object]
• [object Object]
• [object Object]